Page last updated: 2024-09-05

n-(2-amino-3-(4-isothiocyanatophenyl)propyl)cyclohexane-1,2-diamine-n,n',n',n'',n''-pentaacetic acid and Experimental Neoplasms

n-(2-amino-3-(4-isothiocyanatophenyl)propyl)cyclohexane-1,2-diamine-n,n',n',n'',n''-pentaacetic acid has been researched along with Experimental Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albone, EF; Campo, MF; Cheng, KT; Choyke, PL; Hassan, R; Kim, HS; Lee, SM; Paik, CH; Pastan, I; Regino, C; Sato, N; Shin, IS; Yao, Z1
Biddlecombe, GB; Boswell, CA; Brechbiel, MW; Clifford, T; Lewis, JS1
Carlsson, J; Friedman, M; Glimelius, B; Nilsson, FY; Nordberg, E; Orlova, A; Ståhl, S; Tolmachev, V1

Other Studies

3 other study(ies) available for n-(2-amino-3-(4-isothiocyanatophenyl)propyl)cyclohexane-1,2-diamine-n,n',n',n'',n''-pentaacetic acid and Experimental Neoplasms

ArticleYear
Effect of chelator conjugation level and injection dose on tumor and organ uptake of 111In-labeled MORAb-009, an anti-mesothelin antibody.
    Nuclear medicine and biology, 2011, Volume: 38, Issue:8

    Topics: Animals; Antibodies, Monoclonal; Chelating Agents; Dose-Response Relationship, Radiation; GPI-Linked Proteins; Indium Radioisotopes; Isothiocyanates; Liver; Mesothelin; Mice; Mice, Nude; Neoplasms, Experimental; Pentetic Acid; Spleen; Tissue Distribution

2011
Validation of a novel CHX-A'' derivative suitable for peptide conjugation: small animal PET/CT imaging using yttrium-86-CHX-A''-octreotide.
    Journal of medicinal chemistry, 2006, Jul-13, Volume: 49, Issue:14

    Topics: Animals; Isothiocyanates; Isotope Labeling; Male; Neoplasm Transplantation; Neoplasms, Experimental; Octreotide; Pentetic Acid; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Inbred Lew; Tissue Distribution; Yttrium Radioisotopes

2006
In vivo and in vitro uptake of 111In, delivered with the affibody molecule (ZEGFR:955)2, in EGFR expressing tumour cells.
    Oncology reports, 2008, Volume: 19, Issue:4

    Topics: Animals; Cell Line, Tumor; ErbB Receptors; Female; Humans; Indium Radioisotopes; Isothiocyanates; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Pentetic Acid; Radiopharmaceuticals; Tissue Distribution

2008